Table 2.
Overall (n = 833) | Anxious (1) (n = 233) | Atypic (2) (n = 61) | Melancholic (3) (n = 43) | Unspecific (4) (n = 365) | p‐Valuea | Post‐testc | ||
---|---|---|---|---|---|---|---|---|
Early improvementc | Yes (%) | 546 (66%) | 139 (60%) | 37 (61%) | 39 (91%) | 246 (67%) | 0.0149 | 1–3 (0.022) |
Responsec | Yes (%) | 595 (71%) | 166 (71%) | 42 (69%) | 37 (86%) | 259 (71%) | 0.39 | |
Remissionc | Yes (%) | 465 (56%) | 125 (54%) | 35 (57%) | 25 (58%) | 223 (61%) | 0.93 | |
Duration of hospital stayd (days) | Mean (median) ± IQR (range) | 63.3 (55) ± 47.0 (1–363) | 66.0 (56) ± 46.0 | 70.4 (56) ± 38.0 | 54.9 (44) ± 48.0 | 61.5 (50) ± 49.0 | 0.149$ | |
MADRSb at discharge | Mean (median) ± SD | 11.2 (9.0) ± 8.83 | 12.1 (10.0) ± 9.20 | 11.1 (9.0) ± 8.86 | 9.4 (8.0) ± 8.69 | 10.1 (8.0) ± 8.34 | 0.267 | |
Relative change of MADRSb | Mean (median) ± SD | –61.1 (−68.8) ± 31.8 | −60.1 (−69.7) ± 34.0 | −56.3 (−63.2) ± 35.0 | −71.2 (−76.9) ± 26.2 | −61.8 (−69.2) ± 31.8 | 0.369 | |
Treatment resistance indexd (range 3–15) | Mean (median) ± IQR (range) [missing] | 7.0 (7) ± 2.0 (4–13) [117] | 7.0 (7) ± 2.0 [35] | 7.0 (7) ± 2.0 [6] | 7.0 (7) ± 2.0 [7] | 6.9 (7) ± 2.0 [40] | 0.743$ | |
GAFb at discharge | Mean (median) ± SD [missing] | 69.9 (70.0) ± 11.4 [83] | 69.3 (70.0) ± 11.9 [23] | 67.4 (70.0) ± 9.3 [2] | 72.2 (70.0) ± 12.8 [3] | 71.4 (70.0) ± 10.8 [45] | 0.266 | |
SOFASb at discharge | Mean (median) ± SD [missing] | 68.4 (70.0) ± 11.5 [89] | 68.3 (70.0) ± 11.2 [26] | 65.6 (65.0) ± 10.9 [4] | 70.8 (70.0) ± 12.0 [3] | 69.5 (70.0) ± 11.6 [47] | 0.368 | |
NEO‐FFI neuroticismb at discharge | Mean (median) ± SD [missing] | 2.2 (2.2) ± 0.67 [297] | 2.3 (2.2) ± 0.67 [92] | 2.3 (2.2) ± 0.62 [21] | 2.0 (2.2) ± 0.63 [16] | 2.1 (2.1) ± 0.67 [127] | 0.258 | |
NEO‐FFI extraversionb at discharge | Mean (median) ± SD [missing] | 1.9 (1.9) ± 0.50 [297] | 1.9 (1.9) ± 0.49 [92] | 1.8 (1.9) ± 0.54 [21] | 1.9 (1.9) ± 0.57 [16] | 2.0 (2.0) ± 0.52 [127] | 0.383 | |
NEO‐FFI opennessb at discharge | Mean (median) ± SD [missing] | 2.3 (2.2) ± 0.48 [297] | 2.3 (2.2) ± 0.48 [92] | 2.3 (2.4) ± 0.51 [21] | 2.3 (2.2) ± 0.45 [16] | 2.3 (2.2) ± 0.49 [127] | 0.792 | |
NEO‐FFI toleranceb at discharge | Mean (median) ± SD [missing] | 2.6 (2.5) ± 0.44 [297] | 2.6 (2.6) ± 0.45 [92] | 2.5 (2.5) ± 0.40 [21] | 2.6 (2.6) ± 0.46 [16] | 2.6 (2.5) ± 0.43 [127] | 0.838 | |
NEO‐FFI conscientiousb at discharge | Mean (median) ± SD [missing] | 2.6 (2.6) ± 0.53 [297] | 2.5 (2.4) ± 0.56 [92] | 2.6 (2.7) ± 0.50 [21] | 2.7 (2.8) ± 0.56 [16] | 2.6 (2.6) ± 0.53 [127] | 0.0093 | 1–3 (0.01) |
Wald test for the subtype in a mixed regression model with centre as a random effect (logistic model for the three outcome criteria, Gaussian otherwise).
For these variables, statistical group comparisons are adjusted for baseline MADRS‐scores, other variables at discharge are adjusted for their respective baseline values.
With square root transformation of the duration to support a Gaussian model.
Pairwise comparisons were adjusted for multiple testing using Holm's method.
The treatment resistance index was calculated based on the “Maudsley Staging” method with some modifications due to missing data as described in the main text.